Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2021-12-31 |
2021-01-01 to 2021-12-31 |
As at 2020-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification | — |
Xspray
|
— |
| Domicile of entity | — |
Solna
|
— |
| Legal form of entity | — |
aktiebolag
|
— |
| Country of incorporation | — |
Sverige
|
— |
| Address of entity's registered office | — |
Råsundavägen 12
|
— |
| Principal place of business | — |
Sverige
|
— |
| Description of nature of entity's operations and principal activities | — |
Xspray Pharma AB (publ) är ett läkemedelsbolag med ett antal produktkandidater under klinisk utveckling.
|
— |
| Name of parent entity | — |
Xspray Pharma
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
6 199
SEK
|
— |
-
SEK
|
| Current trade payables |
16 865
SEK
|
— |
8 438
SEK
|